Skip to content

Clinical study on multi-modal data fusion of integrated traditional Chinese and western medicine for auxiliary diagnosis and curative effect evaluation of depression and anxiety disorder

Clinical study on multi-modal data fusion of integrated traditional Chinese and western medicine for auxiliary diagnosis and curative effect evaluation of depression and anxiety disorder

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086651
Enrollment
Unknown
Registered
2024-07-08
Start date
2024-07-08
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression and anxiety disorder

Interventions

Gold Standard:Meets the diagnostic criteria for depression or generalized anxiety disorder in DSM-5
Index test:Multi-modal data fusion of traditional Chinese and western medicine is used to objectively diagnose depression and anxiety: Chinese medicine's sight, smell, question and pulse are based on
Western medicine: brain functional imaging acquisition: resting-state functional magnetic resonance imaging (rsfMRI), task-state functional magnetic resonance imaging (tfMRI), near-infrared brain func

Sponsors

Huzhou Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The criteria for patients in the disease group include: ? Patients with depression, anxiety, and depression complicated with anxiety assessed by SCID by a psychiatrist trained in depression and anxiety research and a senior psychiatrist; ? Meet the diagnostic criteria of depression or generalized anxiety disorder in DSM-5; ?HAMD- 24 score =17 or HAMA- 14 score =14; ? The age is 18 ~ 60 years; ? The current course of disease (last onset) is at least 2 weeks; ? No electroconvulsive therapy was given in the first half year; ? Being conscious and communicating smoothly, voluntarily participating and signing the informed consent form; ?Being right-handed. The criteria for admission to the control group include: ? Aged from 18 to 60; ?HAMD-24 score < 7, HAMA-17 score < 7; ? No serious physical illness, no history of mental illness, alcohol and drug abuse; (4) conscious, smooth communication, voluntary participation and signed informed consent; ? Right-handed.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients in disease group include: (1) combined with another mental illness; ? Have a history of alcohol/drug dependence or smoke more than 10 cigarettes/day; ? Serious somatic diseases of heart, liver, kidney, brain and hematopoietic system, central nervous system infection, head injury, epilepsy, multiple sclerosis, toxic metabolic diseases, Parkinson's disease or intracranial tumors; ? Family history of hereditary diseases; ? Endocrine diseases such as diabetes, hyperthyroidism or hypothyroidism; ? Pregnant and lactating women or people who are allergic to light. Exclusion criteria of control group: (1) those who have a family history of mental illness within two families and three generations; ? Pregnant and lactating women or people who are allergic to light.

Design outcomes

Primary

MeasureTime frame
Eye movement index;EEG index;specificity;

Secondary

MeasureTime frame
Heart rate variability;sensitivity;

Countries

China

Contacts

Public ContactZhongxia Shen

Huzhou Third People's Hospital

snowszx@sina.com+86 137 5727 5095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026